Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back Pain
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Patients who had axial lower back pain (LBP) with or without radiation present for at least 3
months and had daily moderate to severe LBP as the primary source of pain participated in a
Phase IV clinical trial to assess the efficacy of lidocaine patch 5% compared to celecoxib
200 mg in treating chronic axial LBP with and without radiation.